Click to Share

Filter News
Show All Results
News By Country
News By Tag
Biobanking Remove

October 2021

Public Company News

Business Press Releases

Biobanking Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Krishagni Solutions
Current Adoption Status: 67 collection protocols / 40+ active usersPublished 67 peer-reviewed articlesSupported 20 grantsManages 400K specimens for 40K study participants100+K specimens sent to Precision Medicine platform *Reference: 2019 OpenSpecimen...
By Krishagni Solutions
The  Mouse Biology Program (MBP) of the University of California, Davis (UCD) is the largest academic program in the world. MBP is a member of the NIH-funded Mutant Mouse Resource and Research Centers (MMRRC).
By OpenSpecimen
Srikanth Adiga (CEO, OpenSpecimen) talks to Dave Mulvihill and Lee Myrick from Washington University's "OpenSpecimen Implementation Team" to understand their internal processes, training mechanisms, & best practices.
By OpenSpecimen
Currently, biobanks at the University Hospital Basel (USB) are not centralized. Storage locations are distributed over organizational units, which partly are about to be centrally managed.
By OpenSpecimen
University of California (Davis) Pathology Biorepository has been using OpenSpecimen as their Biobanking LIMS since 2010. We interview Irmi Feldman (Biorepostiory Manager) to understand the work and life of a biobanker.
By OpenSpecimen
The University of Maryland School of Medicine established a biorepository intending to provide the resources and support for large-scale studies. Currently, the UMM Biorepository has data of 28000+ participants and 400000+ specimens.
By OpenSpecimen
"According to Darwin's Origin of Species, it is not the strongest of the species that survives, nor the most intellectual; but the one most adaptable to change." – Leon C.
By AXT Pty Ltd
The Victorian Cancer Biobank (VCB) is a crucial part of the medical research landscape supporting researchers throughout Australia and around the world with the aim of delivering better clinical outcomes to people suffering with cancer.
By Fact.MR
According to the study, the biobanking market would advance at a healthy CAGR of 7% during the forecast period 2020 - 27.

Page updated every 10 minutes

Like PRLog?
Click to Share